A physical interaction between the adaptor proteins DOK3 and DAP12 Is required to inhibit lipopolysaccharide signaling in macrophages

Science Signaling

Volumn 6, Issue 289, 2013, Pages

  Peng, Qisheng ^a   Long, Courtney L ^b   Malhotra, Shikha ^b,c   Humphrey, Mary Beth ^b,d  

^a JILIN UNIVERSITY   (China)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c Gentrac Life Biotechnology   (India)

^d DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; BETA ACTIN; I KAPPA B ALPHA; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOTYROSINE; PROTEIN DOK3; PROTEIN TREM2; PROTEIN TYROSINE KINASE; RECEPTOR PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW CELL; CELL MEMBRANE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL LINE; CELL MEMBRANE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MEMBRANE GLYCOPROTEINS; MICE; MICE, MUTANT STRAINS; PHOSPHORYLATION; PROTEIN TRANSPORT; RECEPTORS, IMMUNOLOGIC; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84884244703     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2003801     Document Type: Article

References (39)

1. P. D. Cani, R. Bibiloni, C. Knauf, A. Waget, A. M. Neyrinck, N. M. Delzenne, R. Burcelin, Changes in gut microbiota control metabolic endotoxemia-induced inflammation in highfat diet-induced obesity and diabetes in mice. Diabetes 57, 1470-1481 (2008).
2. T. Goto, S. Edén, G. Nordenstam, V. Sundh, C. Svanborg- Edén, I. Mattsby-Baltzer, Endotoxin levels in sera of elderly individuals. Clin. Diagn. Lab. Immunol. 1, 684-688 (1994).
3. J. M. Moreno-Navarrete, M. Manco, J. Ibáñez, E. García-Fuentes, F. Ortega, E. Gorostiaga, J. Vendrell, M. Izquierdo, C. Martínez, G. Nolfe, W. Ricart, G. Mingrone, F. Tinahones, J. M. Fernández-Real, Metabolic endotoxemia and saturated fat contribute to circulating NGAL concentrations in subjects with insulin resistance. Int. J. Obes. 34, 240-249 (2010).
4. P. Wiesner, S. H. Choi, F. Almazan, C. Benner, W. Huang, C. J. Diehl, A. Gonen, S. Butler, J. L. Witztum, C. K. Glass, Y. I. Miller, Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor kB and activator protein-1: Possible mechanism for acceleration of atherosclerosis by subclinical endotoxemia. Circ. Res. 107, 56-65 (2010).
5. L. Qin, X. Wu, M. L. Block, Y. Liu, G. R. Breese, J. S. Hong, D. J. Knapp, F. T. Crews, Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55, 453-462 (2007).
6. U. Maitra, L. Gan, S. Chang, L. Li, Low-dose endotoxin induces inflammation by selectively removing nuclear receptors and activating CCAAT/enhancer-binding protein d. J. Immunol. 186, 4467-4473 (2011).
7. L. L. Lanier, B. C. Corliss, J. Wu, C. Leong, J. H. Phillips, Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391, 703-707 (1998).
8. L. Olcese, A. Cambiaggi, G. Semenzato, C. Bottino, A. Moretta, E. Vivier, Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J. Immunol. 158, 5083-5086 (1997).
9. E. Tomasello, L. Olcese, F. Vély, C. Geourgeon, M. Bléry, A. Moqrich, D. Gautheret, M. Djabali, M. G. Mattei, E. Vivier, Gene structure, expression pattern, and biological activity of mouse killer cell activating receptor-Associated protein (KARAP)/DAP-12. J. Biol. Chem. 273, 34115-34119 (1998).
10. K. S. Campbell, M. Cella, M. Carretero, M. López-Botet, M. Colonna, Signaling through human killer cell activating receptors triggers tyrosine phosphorylation of an associated protein complex. Eur. J. Immunol. 28, 599-609 (1998).
11. J. A. Hamerman, M. Ni, J. R. Killebrew, C. L. Chu, C. A. Lowell, The expanding roles of ITAM adapters FcRg and DAP12 in myeloid cells. Immunol. Rev. 232, 42-58 (2009).
12. J. A. Hamerman, N. K. Tchao, C. A. Lowell, L. L. Lanier, Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. Nat. Immunol. 6, 579-586 (2005).
13. J. A. Hamerman, J. R. Jarjoura, M. B. Humphrey, M. C. Nakamura, W. E. Seaman, L. L. Lanier, Cutting edge: Inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J. Immunol. 177, 2051-2055 (2006).
14. I. R. Turnbull, S. Gilfillan, M. Cella, T. Aoshi, M. Miller, L. Piccio, M. Hernandez, M. Colonna, Cutting edge: TREM-2 attenuates macrophage activation. J. Immunol. 177, 3520-3524 (2006).
15. Q. Peng, J. L. O'Loughlin, M. B. Humphrey, DOK3 negatively regulates LPS responses and endotoxin tolerance. PLoS One 7, e39967 (2012).
16. H. Shinohara, A. Inoue, N. Toyama-Sorimachi, Y. Nagai, T. Yasuda, H. Suzuki, R. Horai, Y. Iwakura, T. Yamamoto, H. Karasuyama, K. Miyake, Y. Yamanashi, Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling. J. Exp. Med. 201, 333-339 (2005).
17. R. Mashima, Y. Hishida, T. Tezuka, Y. Yamanashi, The roles of Dok family adapters in immunoreceptor signaling. Immunol. Rev. 232, 273-285 (2009).
18. M. Honma, O. Higuchi, M. Shirakata, T. Yasuda, H. Shibuya, S. Iemura, T. Natsume, Y. Yamanashi, Dok-3 sequesters Grb2 and inhibits the Ras-Erk pathway downstream of protein-Tyrosine kinases. Genes Cells 11, 143-151 (2006).
19. A. H. Berger, M. Niki, A. Morotti, B. S. Taylor, N. D. Socci, A. Viale, C. Brennan, J. Szoke, N. Motoi, P. B. Rothman, J. Teruya-Feldstein, W. L. Gerald, M. Ladanyi, P. P. Pandolfi, Identification of DOK genes as lung tumor suppressors. Nat. Genet. 42, 216-223 (2010).
20. R. Mashima, K. Honda, Y. Yang, Y. Morita, A. Inoue, S. Arimura, H. Nishina, H. Ema, H. Nakauchi, B. Seed, H. Oda, Y. Yamanashi, Mice lacking Dok-1, Dok-2, and Dok-3 succumb to aggressive histiocytic sarcoma. Lab. Invest. 90, 1357-1364 (2010).
21. S. Dong, B. Corre, E. Foulon, E. Dufour, A. Veillette, O. Acuto, F. Michel, T cell receptor for antigen induces linker for activation of T cell-dependent activation of a negative signaling complex involving Dok-2, SHIP-1, and Grb-2. J. Exp. Med. 203, 2509-2518 (2006).
22. F. Cong, B. Yuan, S. P. Goff, Characterization of a novel member of the DOK family that binds and modulates Abl signaling. Mol. Cell. Biol. 19, 8314-8325 (1999).
23. D. W. McVicar, L. S. Taylor, P. Gosselin, J. Willette-Brown, A. I. Mikhael, R. L. Geahlen, M. C. Nakamura, P. Linnemeyer, W. E. Seaman, S. K. Anderson, J. R. Ortaldo, L. H. Mason, DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk protein-Tyrosine kinase. J. Biol. Chem. 273, 32934-32942 (1998).
24. K. Neumann, T. Oellerich, I. Heine, H. Urlaub, M. Engelke, Fc gamma receptor IIb modulates the molecular Grb2 interaction network in activated B cells. Cell. Signal. 23, 893-900 (2011).
25. Y. A. Senis, R. Antrobus, S. Severin, A. F. Parguiña, I. Rosa, N. Zitzmann, S. P. Watson, A. García, Proteomic analysis of integrin aIIbb3 outside-in signaling reveals Src-kinaseindependent phosphorylation of Dok-1 and Dok-3 leading to SHIP-1 interactions. J. Thromb. Haemost. 7, 1718-1726 (2009).
26. B. Stork, K. Neumann, I. Goldbeck, S. Alers, T. Kähne, M. Naumann, M. Engelke, J. Wienands, Subcellular localization of Grb2 by the adaptor protein Dok-3 restricts the intensity of Ca2+ signaling in B cells. EMBO J. 26, 1140-1149 (2007).
27. J. D. Robson, D. Davidson, A. Veillette, Inhibition of the Jun N-Terminal protein kinase pathway by SHIP-1, a lipid phosphatase that interacts with the adaptor molecule Dok-3. Mol. Cell. Biol. 24, 2332-2343 (2004).
28. S. Lemay, D. Davidson, S. Latour, A. Veillette, Dok-3, a novel adapter molecule involved in the negative regulation of immunoreceptor signaling. Mol. Cell. Biol. 20, 2743-2754 (2000).
29. C. Han, J. Jin, S. Xu, H. Liu, N. Li, X. Cao, Integrin CD11b negatively regulates TLRtriggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b. Nat. Immunol. 11, 734-742 (2010).
30. Q. Peng, S. Malhotra, J. A. Torchia, W. G. Kerr, K. M. Coggeshall, M. B. Humphrey, TREM2-And DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1. Sci. Signal. 3, ra38 (2010).
31. M. E. March, K. Ravichandran, Regulation of the immune response by SHIP. Semin. Immunol. 14, 37-47 (2002).
32. E. J. Downer, D. G. Johnston, M. A. Lynch, Differential role of Dok1 and Dok2 in TLR2-induced inflammatory signaling in glia. Mol. Cell. Neurosci. 56C, 148-158 (2013).
33. A. Mócsai, C. L. Abram, Z. Jakus, Y. Hu, L. L. Lanier, C. A. Lowell, Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosinebased activation motifs. Nat. Immunol. 7, 1326-1333 (2006).
34. H. An, H. Xu, M. Zhang, J. Zhou, T. Feng, C. Qian, R. Qi, X. Cao, Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity-And PI-3K-independent mechanism. Blood 105, 4685-4692 (2005).
35. H. Fang, R. A. Pengal, X. Cao, L. P. Ganesan, M. D. Wewers, C. B. Marsh, S. Tridandapani, Lipopolysaccharide-induced macrophage inflammatory response is regulated by SHIP. J. Immunol. 173, 360-366 (2004).
36. M. B. Humphrey, M. R. Daws, S. C. Spusta, E. C. Niemi, J. A. Torchia, L. L. Lanier, W. E. Seaman, M. C. Nakamura, TREM2, a DAP12-Associated receptor, regulates osteoclast differentiation and function. J. Bone Miner. Res. 21, 237-245 (2006).
37. S. Tridandapani, T. Kelley, M. Pradhan, D. Cooney, L. B. Justement, K. M. Coggeshall, Recruitment and phosphorylation of SH2-containing inositol phosphatase and Shc to the B-cell Fcg immunoreceptor tyrosine-based inhibition motif peptide motif. Mol. Cell. Biol. 17, 4305-4311 (1997).
38. S. Tridandapani, M. Pradhan, J. R. LaDine, S. Garber, C. L. Anderson, K. M. Coggeshall, Protein interactions of Src homology 2 (SH2) domain-containing inositol phosphatase (SHIP): Association with Shc displaces SHIP from FcgRIIb in B cells. J. Immunol. 162, 1408-1414 (1999).
39. A. Mócsai, M. B. Humphrey, J. A. Van Ziffle, Y. Hu, A. Burghardt, S. C. Spusta, S. Majumdar, L. L. Lanier, C. A. Lowell, M. C. Nakamura, The immunomodulatory adapter proteins DAP12 and Fc receptor g-chain (FcRg) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc. Natl. Acad. Sci. U.S.A. 101, 6158-6163 (2004).